President & Chief Executive Officer
FivePrime Pharmaceuticals

FivePrime President & CEO, Gail Maderis, joined in July 2003. Prior to joining FivePrime, she spent 11 years at Genzyme Corporation in various business development and general management positions. While at Genzyme, she founded and served as president of Genzyme Molecular Oncology, a publicly-traded tracking stock division involved in discovery and development of novel cancer therapies, and was appointed a corporate vice president of Genzyme Corporation. Prior to Genzyme, Maderis practiced management and strategy consulting with Bain & Co., Inc. Previously, Maderis was a member of the Scientific Advisory Board of the Canadian Medical Discoveries Fund and a member of the Board of Directors of the New York Pharma Forum. She received a B.S. degree in business from the University of California at Berkeley and an MBA from Harvard Business School.